INCREASED IN ACUTE HEALTH CARE USE AMONG PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND CO-MORBID DEPRESSION IN ONTARIO- A LONGITUDINAL STUDY
Author(s)
Choi S1, Boyle E2, Cairney J3, Carvalhal A4, Collins EJ5, Krahn MD6, Kumar M7, Grootendorst P1, Rourke SB8
1University of Toronto, Toronto, ON, Canada, 2university of southern denmark, Odense, Denmark, 3McMaster University, Hamilton, ON, Canada, 4St. Michael's Hospital, Toronto, ON, Canada, 5University Health Network, Toronto, ON, Canada, 6Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada, 7Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 8Ontario HIV Treatment Network, Toronto, ON, Canada
OBJECTIVES: Depression is a common co-morbidity among people living with HIV. Co-morbid depression often leads to poor self-management and non-adherence to antiretroviral therapy which may result in increased use of emergency and inpatient care. We aimed to examine impacts of co-morbid depression on acute health care utilization over time among this high-need population in Ontario. METHODS: A longitudinal HIV+ cohort study of Ontarians(N=3,545) was undertaken from 2008-2012 by linking the Ontario HIV Treatment Network(OHTN) Cohort Study and the administrative health databases. Co-morbid depression defined based on either the Center for Epidemiologic Studies Depression Scale(Scores>=20) or the Kessler Psychological Distress Scale(Scores>=23) was assessed from the yearly interviews. Patterns of emergency and inpatient care utilization were assessed during the 12 months following each interview. Urgent and non-urgent emergency room visits were defined using the five-level Canadian Triage and Acuity Scale(CTAS). Generalized mixed effect regressions were used to examine associations between the acute care utilization and the co-morbid depression over time. RESULTS: At baseline, 950(27%) were identified with co-morbid depression. The HIV+ patients with co-morbid depression were more likely to be age<50 years(OR:1.6;95%CI:1.4-1.9), female(OR:1.6;95%CI:1.3-1.9), have CD4 count<200cell/mm(OR:1.3;95%CI:1.1-1.7) and have used non-medical drugs in past 6 months(OR:1.8;95%CI:1.5-2.1). The prevalence of the use of urgent and non-urgent emergency room and inpatient care for those with co-morbid depression were 58vs.42%,44vs.31%,13vs.7% when compared to their non-depressed counterparts. Over the five-year follow-up, those with co-morbid depression were more likely to use urgent (Adjusted OR (aOR):1.7;95%CI:1.2-2.5) and non-urgent (aOR:1.4;95%CI:1.03-2.0) emergency services and to be hospitalized (aOR: 1.6;95%CI:1.3-2.1) when compared to their non-depressed counterparts after controlling for socio-demographics, clinical markers, and behaviourial confounders. CONCLUSIONS: Co-morbid depression experienced in persons living with HIV significantly increases the use of acute care services. Incorporation of strategies in managing and detecting co-morbid depression would be important to deliver successful HIV care in Ontario.
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PHS107
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Treatment Patterns and Guidelines
Disease
Infectious Disease (non-vaccine), Mental Health
Explore Related HEOR by Topic